U.S. Markets open in 6 hrs 54 mins

Angion Biomedica Corp. (ANGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.2800+0.0400 (+3.23%)
At close: 04:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 316.0350
52 Week Low 31.0750
50-Day Moving Average 31.7449
200-Day Moving Average 34.6661

Share Statistics

Avg Vol (3 month) 391.42k
Avg Vol (10 day) 3128.71k
Shares Outstanding 529.96M
Implied Shares Outstanding 6N/A
Float 821.64M
% Held by Insiders 127.35%
% Held by Institutions 123.32%
Shares Short (Apr 28, 2022) 4649.47k
Short Ratio (Apr 28, 2022) 48.15
Short % of Float (Apr 28, 2022) 42.55%
Short % of Shares Outstanding (Apr 28, 2022) 42.17%
Shares Short (prior month Mar 30, 2022) 4494.51k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin -192.76%
Operating Margin (ttm)-138.84%

Management Effectiveness

Return on Assets (ttm)-34.15%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)28.31M
Revenue Per Share (ttm)1.00
Quarterly Revenue Growth (yoy)5,551.60%
Gross Profit (ttm)-20.82M
EBITDA -39.22M
Net Income Avi to Common (ttm)-54.57M
Diluted EPS (ttm)-4.0040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)88.76M
Total Cash Per Share (mrq)2.96
Total Debt (mrq)4.66M
Total Debt/Equity (mrq)5.72
Current Ratio (mrq)8.08
Book Value Per Share (mrq)2.15

Cash Flow Statement

Operating Cash Flow (ttm)-52.64M
Levered Free Cash Flow (ttm)-22.72M